These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 1902858)

  • 1. Endogenous IFN-gamma is required for resistance to acute Trypanosoma cruzi infection in mice.
    Torrico F; Heremans H; Rivera MT; Van Marck E; Billiau A; Carlier Y
    J Immunol; 1991 May; 146(10):3626-32. PubMed ID: 1902858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [TH1 response in the experimental infection with Trypanosoma cruzi].
    Cardoni RL; Antúnez MI; Abrami AA
    Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo administration of recombinant IFN-gamma induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections.
    Reed SG
    J Immunol; 1988 Jun; 140(12):4342-7. PubMed ID: 3131431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trypanosoma cruzi: IL-10, TNF, IFN-gamma, and IL-12 regulate innate and acquired immunity to infection.
    Abrahamsohn IA; Coffman RL
    Exp Parasitol; 1996 Nov; 84(2):231-44. PubMed ID: 8932773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic analysis of antigen-specific immune responses in resistant and susceptible mice during infection with Trypanosoma cruzi.
    Hoft DF; Lynch RG; Kirchhoff LV
    J Immunol; 1993 Dec; 151(12):7038-47. PubMed ID: 8258708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen-specific Il-4- and IL-10-secreting CD4+ lymphocytes increase in vivo susceptibility to Trypanosoma cruzi infection.
    Barbosa de Oliveira LC; Curotto de Lafaille MA; Collet de Araujo Lima GM; de Almeida Abrahamsohn I
    Cell Immunol; 1996 May; 170(1):41-53. PubMed ID: 8660798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi.
    Hunter CA; Ellis-Neyes LA; Slifer T; Kanaly S; Grünig G; Fort M; Rennick D; Araujo FG
    J Immunol; 1997 Apr; 158(7):3311-6. PubMed ID: 9120288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine and nitric oxide regulation of the immunosuppression in Trypanosoma cruzi infection.
    Abrahamsohn IA; Coffman RL
    J Immunol; 1995 Oct; 155(8):3955-63. PubMed ID: 7561103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental visceral leishmaniasis: role of endogenous IFN-gamma in host defense and tissue granulomatous response.
    Squires KE; Schreiber RD; McElrath MJ; Rubin BY; Anderson SL; Murray HW
    J Immunol; 1989 Dec; 143(12):4244-9. PubMed ID: 2512353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic protection by specific antibodies and interferon against infection by Trypanosoma cruzi in vitro.
    Plata F; Wietzerbin J; Pons FG; Falcoff E; Eisen H
    Eur J Immunol; 1984 Oct; 14(10):930-5. PubMed ID: 6208038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trypanosoma cruzi: roles for perforin-dependent and perforin-independent immune mechanisms in acute resistance.
    Nickell SP; Sharma D
    Exp Parasitol; 2000 Apr; 94(4):207-16. PubMed ID: 10831388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage activity, IL-6 levels, antibody response and heart histology in rats undergoing an attenuated Trypanosoma cruzi acute infection upon treatment with recombinant interferon gamma.
    Revelli S; Didoli G; Roggero E; Moreno H; Bernabo J; Wietzerbin J; Bottasso O
    Cytokines Cell Mol Ther; 1998 Sep; 4(3):153-9. PubMed ID: 9825840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trypanosoma cruzi: immunity-induced in mice and rats by trypomastigote excretory-secretory antigens and identification of a peptide sequence containing a T cell epitope with protective activity.
    Taibi A; Plumas-Marty B; Guevara-Espinoza A; Schöneck R; Pessoa H; Loyens M; Piras R; Aguirre T; Gras-Masse H; Bossus M
    J Immunol; 1993 Sep; 151(5):2676-89. PubMed ID: 7689612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute Trypanosoma cruzi infection: IL-12, IL-18, TNF, sTNFR and NO in T. rangeli-vaccinated mice.
    Basso B; Cervetta L; Moretti E; Carlier Y; Truyens C
    Vaccine; 2004 May; 22(15-16):1868-72. PubMed ID: 15121297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ T cells.
    Sadick MD; Heinzel FP; Shigekane VM; Fisher WL; Locksley RM
    J Immunol; 1987 Aug; 139(4):1303-9. PubMed ID: 3112230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical involvement of interferon gamma in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestations of hepatitis.
    Mizuhara H; Uno M; Seki N; Yamashita M; Yamaoka M; Ogawa T; Kaneda K; Fujii T; Senoh H; Fujiwara H
    Hepatology; 1996 Jun; 23(6):1608-15. PubMed ID: 8675184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xid-associated resistance to experimental Chagas' disease is IFN-gamma dependent.
    Minoprio P; el Cheikh MC; Murphy E; Hontebeyrie-Joskowicz M; Coffman R; Coutinho A; O'Garra A
    J Immunol; 1993 Oct; 151(8):4200-8. PubMed ID: 8409396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of immune responses raised against Tc13 antigens of Trypanosoma cruzi in the outcome of murine experimental infection.
    García GA; Arnaiz MR; Esteva MI; Laucella SA; Garavaglia PA; Ibarra SE; Ruiz AM
    Parasitology; 2008 Mar; 135(3):347-57. PubMed ID: 17991305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-2 inhibits early increases in serum gamma interferon levels associated with graft-versus-host-disease.
    Szebeni J; Wang MG; Pearson DA; Szot GL; Sykes M
    Transplantation; 1994 Dec; 58(12):1385-93. PubMed ID: 7809932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trypanosoma cruzi triggers an early type I IFN response in vivo at the site of intradermal infection.
    Chessler AD; Unnikrishnan M; Bei AK; Daily JP; Burleigh BA
    J Immunol; 2009 Feb; 182(4):2288-96. PubMed ID: 19201883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.